LEN
Lennar Corporation
LEN trails on the overall score without a compensating advantage in the available component scores.
NKE
NIKE, Inc.
NKE has the edge over LEN overall, supported by stronger valuation and stronger modeled upside.
LEN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
LEN's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
LEN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $35.62 | -57% |
| Fair | 10x | $53.28 | -36% |
| Expensive | 12x | $64.56 | -23% |
| Current | 16x | $83.58 | — |
| Forward | 18x | $83.58 | — |
Historical ranges are pointers, not guarantees.
LEN's PE is in its expensive range at 16x. Analysts expect earnings to fall, which would put today's price at 18x next year's earnings.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over LEN in the historical PE scenario, which offers more potential upside but is not a forecast.
LEN Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect LEN's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
LEN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.68 | -11% |
| Q3 2026 | $5.28 | -48% |
| Q2 2026 | $6.38 | -46% |
| Q1 2026 | $6.95 | -48% |
| Q4 2025 | $7.98 | -43% |
| Q3 2025 | $10.09 | -31% |
| Q2 2025 | $11.92 | -16% |
| Q1 2025 | $13.45 | -2.5% |
| Q4 2024 | $13.98 | +5.2% |
LEN's earnings per share have fallen from their peak: $5.28 over the past year, against $15.58 in early 2023.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over LEN on earnings, with stronger typical year-over-year growth.
LEN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8B | -8.7% |
| Q2 2026 | $7.9B | -5.2% |
| Q1 2026 | $6.6B | -13% |
| Q4 2025 | $9.4B | -5.8% |
| Q3 2025 | $8.8B | -6.4% |
| Q2 2025 | $8.4B | -4.4% |
| Q1 2025 | $7.6B | +4.4% |
| Q4 2024 | $9.9B | -9.3% |
LEN's revenue has slid since its 2023 peak: $8B last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | -2.2 points |
| Q2 2026 | 5% | -2.5 points |
| Q1 2026 | 3.3% | -5.8 points |
| Q4 2025 | 6.9% | -7.8 points |
| Q3 2025 | 7.9% | -5.7 points |
| Q2 2025 | 7.5% | -6.4 points |
| Q1 2025 | 9.1% | -3.2 points |
| Q4 2024 | 15% | -1.6 points |
LEN's operating margin was 5.7% last quarter, down 2.2 points from the same quarter a year ago, near the bottom of its range since 2019.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over LEN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over LEN on profitability, with a higher operating margin.
LEN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$96.3M | +$94.5M |
| Q2 2026 | -$303.2M | +$807M |
| Q1 2026 | -$463.5M | -$118.4M |
| Q4 2025 | $1.7B | +79% |
| Q3 2025 | -$190.8M | -124% |
| Q2 2025 | -$1.1B | -647% |
| Q1 2025 | -$345.1M | -217% |
| Q4 2024 | $933.1M | -63% |
LEN has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
LEN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -3M shares |
| 1 year | -7% | -17.8M shares |
| 3 years | -19% | -54.4M shares |
| 5 years | -25% | -79.7M shares |
| Available history | -28% | -91.2M shares |
LEN has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $255.9M |
| Q2 2026 | $467.1M |
| Q1 2026 | $269.7M |
| Q4 2025 | $57,000 |
| Q3 2025 | $512.4M |
| Q2 2025 | $521.4M |
| Q1 2025 | $774.5M |
| Q4 2024 | $527.2M |
LEN spent $993M buying back its own shares over the past year, down 57% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
LEN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
LEN has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
LEN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.3 | Neutral |
| Stochastic | 69.2 | Neutral |
LEN's weekly RSI is 46 (neutral) and its Stochastic is 69 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
LEN PE vs Consumer Cyclical Sector
| Metric | LEN | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 12% below |
| PE % | 99 | 47 | 52 pts above |
LEN has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
LEN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $82.5 | 1.3% above |
| 20 week MA | $83.6 | 0% above |
| 50 week MA | $94.0 | 11% below |
| 100 week MA | $107.5 | 22% below |
| 200 week MA | $123.9 | 33% below |
LEN has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
LEN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.0 | $80.4 | +44% |
| 2021 | $80.4 | $112.1 | +39% |
| 2022 | $112.1 | $90.6 | -19% |
| 2023 | $90.6 | $149.0 | +64% |
| 2024 | $149.0 | $137.2 | -8% |
| 2025 | $137.2 | $104.9 | -24% |
| 2026 YTD | $104.9 | $83.6 | -20% |
LEN has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.